Home › Companies › ANAPTYSBIO INC. › 2023-2024
Compiled from SEC Form N-PX filings and ANAPTYSBIO INC.’s Form 8-K, filed June 12, 2024 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of June 12, 2024: 6 items on ANAPTYSBIO INC.’s Form 8-K, filed June 12, 2024: 6 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024 2024-2025
Explore ANAPTYSBIO INC. in the interactive database Compare manager voting policies
These tallies are ANAPTYSBIO INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 12, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Daniel Faga | 22,287,039 | -- | -- | 545,311 | 1,943,741 | 98% | Not verified | — |
| Elect Director: Dennis Fenton, Ph.D. | 21,883,756 | -- | -- | 948,594 | 1,943,741 | 96% | Not verified | — |
| Elect Director: Oleg Nodelman | 18,793,914 | -- | -- | 3,885,244 | 2,096,933 | 83% | Not verified | — |
| 2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 | 24,744,224 | 30,261 | 1,606 | -- | -- | 99.8% | Not verified | — |
| 3. Non-binding, advisory approval of compensation paid to the Company's named executive officers | 19,874,097 | 2,954,956 | 3,397 | -- | 1,943,641 | 87% | Not verified | — |
| 4. Approval of the amendment and restatement of the Company's 2017 Equity Incentive Plan | 16,839,857 | 4,686,098 | 1,306,496 | -- | 1,943,640 | 78% | Not verified | — |
Source: ANAPTYSBIO INC., Form 8-K, filed with the SEC on June 12, 2024 — read the filing on EDGAR.
Each item below shows how the 168 asset managers that disclosed a ANAPTYSBIO INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To elect three Class I directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: Daniel Faga
ANAPTYSBIO INC.’s own tally for this item (“Elect Director: Daniel Faga”): 22,287,039 for, 545,311 withheld, per its Form 8-K filed June 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 5,009,403 for, 444,041 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,313,911 | 0 | 0 | 0 | For |
| BlackRock | 838,960 | 0 | 0 | 0 | For |
| State Street | 741,160 | 0 | 0 | 831 | For |
| MUTUAL FUND SERIES TRUST | 568,324 | 0 | 0 | 0 | For |
| Fidelity | 401,964 | 0 | 0 | 139,628 | Mixed |
| Dimensional | 0 | 0 | 0 | 287,176 | Withhold |
| T. Rowe Price | 201,426 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 160,679 | 0 | 0 | 0 | For |
| Charles Schwab | 146,406 | 0 | 0 | 0 | For |
| Victory Capital | 124,134 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 93,732 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 70,688 | 0 | 0 | 0 | For |
| Equitable | 63,086 | 0 | 0 | 0 | For |
| TIAA | 52,595 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 35,735 | 0 | 0 | 0 | For |
| Federated Hermes | 35,552 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,600 | 0 | 0 | 3,698 | Mixed |
| ALPS ETF Trust | 18,602 | 0 | 0 | 0 | For |
| ProShares | 17,961 | 0 | 0 | 0 | For |
| John Hancock | 14,627 | 0 | 0 | 0 | For |
| Nushares ETF Trust | 11,106 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 9,232 | 0 | 0 | 0 | For |
| Global X | 8,602 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 0 | 7,129 | Withhold |
| SEI | 7,100 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: To elect three Class I directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: Dennis Fenton, Ph.D.
ANAPTYSBIO INC.’s own tally for this item (“Elect Director: Dennis Fenton, Ph.D.”): 21,883,756 for, 948,594 withheld, per its Form 8-K filed June 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 4,706,846 for, 746,598 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,313,911 | 0 | 0 | 0 | For |
| BlackRock | 838,960 | 0 | 0 | 0 | For |
| State Street | 741,160 | 0 | 0 | 831 | For |
| MUTUAL FUND SERIES TRUST | 568,324 | 0 | 0 | 0 | For |
| Fidelity | 401,964 | 0 | 0 | 139,628 | Mixed |
| Dimensional | 0 | 0 | 0 | 287,176 | Withhold |
| T. Rowe Price | 0 | 0 | 0 | 201,426 | Withhold |
| FRANKLIN STRATEGIC SERIES | 160,679 | 0 | 0 | 0 | For |
| Charles Schwab | 146,406 | 0 | 0 | 0 | For |
| Victory Capital | 124,134 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 93,732 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 70,688 | 0 | 0 | 0 | For |
| Equitable | 32,456 | 0 | 0 | 30,630 | Mixed |
| TIAA | 0 | 0 | 0 | 52,595 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 35,735 | 0 | 0 | 0 | For |
| Federated Hermes | 35,552 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,600 | 0 | 0 | 3,698 | Mixed |
| ALPS ETF Trust | 18,602 | 0 | 0 | 0 | For |
| ProShares | 17,961 | 0 | 0 | 0 | For |
| John Hancock | 7,827 | 0 | 0 | 6,800 | Mixed |
| Nushares ETF Trust | 0 | 0 | 0 | 11,106 | Withhold |
| AIG/SunAmerica | 9,232 | 0 | 0 | 0 | For |
| Global X | 8,602 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 0 | 7,129 | Withhold |
| SEI | 7,100 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Combines 4 wordings of this item as funds reported it.
83% Majority: yes · of votes cast
Description as filed by funds: To elect three Class I directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: Oleg Nodelman
ANAPTYSBIO INC.’s own tally for this item (“Elect Director: Oleg Nodelman”): 18,793,914 for, 3,885,244 withheld, per its Form 8-K filed June 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 83% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 3,682,323 for, 85 against, 1,771,036 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,313,911 | 0 | 0 | 0 | For |
| BlackRock | 838,960 | 0 | 0 | 0 | For |
| State Street | 8,007 | 0 | 0 | 733,984 | Withhold |
| MUTUAL FUND SERIES TRUST | 568,324 | 0 | 0 | 0 | For |
| Fidelity | 401,935 | 0 | 0 | 139,657 | Mixed |
| Dimensional | 0 | 0 | 0 | 287,176 | Withhold |
| T. Rowe Price | 201,426 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 160,679 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 146,406 | Withhold |
| Victory Capital | 0 | 0 | 0 | 124,134 | Withhold |
| Delaware/Macquarie | 0 | 0 | 0 | 93,732 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 70,688 | Withhold |
| Equitable | 34,756 | 0 | 0 | 28,330 | Mixed |
| TIAA | 52,595 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 35,735 | 0 | 0 | 0 | For |
| Federated Hermes | 35,552 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 0 | 20,298 | Withhold |
| ALPS ETF Trust | 0 | 0 | 0 | 18,602 | Withhold |
| ProShares | 0 | 0 | 0 | 17,961 | Withhold |
| John Hancock | 6,800 | 0 | 0 | 7,827 | Mixed |
| Nushares ETF Trust | 11,106 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 9,232 | Withhold |
| Global X | 0 | 0 | 0 | 8,602 | Withhold |
| Jackson National | 0 | 0 | 0 | 7,129 | Withhold |
| SEI | 0 | 0 | 0 | 7,100 | Withhold |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Combines 2 wordings of this item as funds reported it.
78% Majority: yes · of votes cast
Description as filed by funds: To approve the amendment and restatement of our 2017 Equity Incentive Plan.
ANAPTYSBIO INC.’s own tally for this item (“4. Approval of the amendment and restatement of the Company's 2017 Equity Incentive Plan”): 16,839,857 for, 4,686,098 against, per its Form 8-K filed June 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 78% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,313,911 | 0 | 0 | 0 | For |
| BlackRock | 838,960 | 0 | 0 | 0 | For |
| State Street | 8,007 | 733,984 | 0 | 0 | Against |
| MUTUAL FUND SERIES TRUST | 568,324 | 0 | 0 | 0 | For |
| Fidelity | 5,355 | 536,237 | 0 | 0 | Against |
| Dimensional | 0 | 287,176 | 0 | 0 | Against |
| T. Rowe Price | 0 | 201,426 | 0 | 0 | Against |
| FRANKLIN STRATEGIC SERIES | 160,679 | 0 | 0 | 0 | For |
| Charles Schwab | 146,406 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 124,134 | 0 | 0 | Against |
| Delaware/Macquarie | 0 | 93,732 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 70,688 | 0 | 0 | Against |
| Equitable | 32,456 | 30,630 | 0 | 0 | Mixed |
| TIAA | 0 | 52,595 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 35,735 | 0 | 0 | 0 | For |
| Federated Hermes | 35,552 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 20,298 | 0 | 0 | Against |
| ALPS ETF Trust | 0 | 18,602 | 0 | 0 | Against |
| ProShares | 0 | 17,961 | 0 | 0 | Against |
| John Hancock | 0 | 14,627 | 0 | 0 | Against |
| Nushares ETF Trust | 0 | 11,106 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 9,232 | 0 | 0 | Against |
| Global X | 8,602 | 0 | 0 | 0 | For |
| Jackson National | 0 | 7,129 | 0 | 0 | Against |
| SEI | 7,100 | 0 | 0 | 0 | For |
Fund voting reports, all 51 managers: 3,174,913 for, 2,278,446 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| First Light Asset Management, LLC | 886,371 | 0 | 0 | 0 | For |
| Palo Alto Investors LP | 803,641 | 0 | 0 | 0 | For |
| Saturn V Capital Management LP | 321,043 | 0 | 0 | 0 | For |
| Keel Point, LLC | 0 | 85 | 0 | 0 | Against |
Institutional-manager reports, all 4 managers: 2,011,055 for, 85 against.
Combines 8 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
Description as filed by funds: TO CONDUCT A NON-BINDING ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE ACCOMPANYING MATERIALS.
ANAPTYSBIO INC.’s own tally for this item (“3. Non-binding, advisory approval of compensation paid to the Company's named executive officers”): 19,874,097 for, 2,954,956 against, per its Form 8-K filed June 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 87% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,313,911 | 0 | 0 | 0 | For |
| BlackRock | 838,960 | 0 | 0 | 0 | For |
| State Street | 731,220 | 10,771 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 568,324 | 0 | 0 | 0 | For |
| Fidelity | 401,935 | 139,657 | 0 | 0 | Mixed |
| Dimensional | 0 | 287,176 | 0 | 0 | Against |
| T. Rowe Price | 0 | 201,426 | 0 | 0 | Against |
| FRANKLIN STRATEGIC SERIES | 160,679 | 0 | 0 | 0 | For |
| Charles Schwab | 146,406 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 124,134 | 0 | 0 | Against |
| Delaware/Macquarie | 0 | 93,732 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 70,688 | 0 | 0 | Against |
| Equitable | 32,456 | 30,630 | 0 | 0 | Mixed |
| TIAA | 0 | 52,595 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 35,735 | 0 | 0 | 0 | For |
| Federated Hermes | 35,552 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,600 | 3,698 | 0 | 0 | Mixed |
| ALPS ETF Trust | 0 | 18,602 | 0 | 0 | Against |
| ProShares | 0 | 17,961 | 0 | 0 | Against |
| John Hancock | 0 | 14,627 | 0 | 0 | Against |
| Nushares ETF Trust | 0 | 11,106 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 9,232 | 0 | 0 | Against |
| Global X | 8,602 | 0 | 0 | 0 | For |
| Jackson National | 0 | 7,129 | 0 | 0 | Against |
| SEI | 7,100 | 0 | 0 | 0 | For |
Fund voting reports, all 51 managers: 4,319,555 for, 1,133,804 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 7,521,024 | 0 | 0 | 0 | For |
| Boxer Capital, LLC | 1,285,217 | 0 | 0 | 0 | For |
| State Street | 1,110,641 | 17,025 | 0 | 0 | For |
| GREAT POINT PARTNERS LLC | 910,546 | 0 | 0 | 0 | For |
| First Light Asset Management, LLC | 886,371 | 0 | 0 | 0 | For |
| Palo Alto Investors LP | 803,641 | 0 | 0 | 0 | For |
| BlackRock | 679,417 | 8,872 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 465,373 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 422,517 | 0 | 0 | 0 | For |
| Woodline Partners LP | 398,966 | 0 | 0 | 0 | For |
| 5AM Venture Management, LLC | 357,733 | 0 | 0 | 0 | For |
| Camber Capital Management LP | 0 | 355,906 | 0 | 0 | Against |
| Saturn V Capital Management LP | 321,043 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 253,008 | 0 | 0 | Against |
| Northern Trust | 160,152 | 308 | 0 | 0 | For |
| Two Sigma | 0 | 153,099 | 0 | 0 | Against |
| Charles Schwab | 146,406 | 0 | 0 | 0 | For |
| Fidelity | 0 | 140,670 | 0 | 0 | Against |
| Victory Capital | 0 | 134,674 | 0 | 0 | Against |
| Hudson Bay Capital Management LP | 0 | 122,864 | 0 | 0 | Against |
| UBS | 0 | 111,673 | 0 | 0 | Against |
| DE Shaw | 0 | 102,298 | 0 | 0 | Against |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 0 | 93,732 | 0 | 0 | Against |
| Citadel | 85,749 | 0 | 0 | 0 | For |
| Ensign Peak Advisors, Inc | 84,204 | 0 | 0 | 0 | For |
Institutional-manager reports, all 130 managers: 15,975,324 for, 2,305,414 against. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Description as filed by funds: To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.
ANAPTYSBIO INC.’s own tally for this item (“2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024”): 24,744,224 for, 30,261 against, per its Form 8-K filed June 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 5,452,172 for, 1,272 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,313,911 | 0 | 0 | 0 | For |
| BlackRock | 838,960 | 0 | 0 | 0 | For |
| State Street | 740,719 | 1,272 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 568,324 | 0 | 0 | 0 | For |
| Fidelity | 541,592 | 0 | 0 | 0 | For |
| Dimensional | 287,176 | 0 | 0 | 0 | For |
| T. Rowe Price | 201,426 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 160,679 | 0 | 0 | 0 | For |
| Charles Schwab | 146,406 | 0 | 0 | 0 | For |
| Victory Capital | 124,134 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 93,732 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 70,688 | 0 | 0 | 0 | For |
| Equitable | 63,086 | 0 | 0 | 0 | For |
| TIAA | 52,595 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 35,735 | 0 | 0 | 0 | For |
| Federated Hermes | 35,552 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,298 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 18,602 | 0 | 0 | 0 | For |
| ProShares | 17,961 | 0 | 0 | 0 | For |
| John Hancock | 14,627 | 0 | 0 | 0 | For |
| Nushares ETF Trust | 11,106 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 9,232 | 0 | 0 | 0 | For |
| Global X | 8,602 | 0 | 0 | 0 | For |
| Jackson National | 7,129 | 0 | 0 | 0 | For |
| SEI | 7,100 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 27,316,644 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.81% |
| 2 | BlackRock | 3.07% |
| 3 | State Street | 2.72% |
| 4 | MUTUAL FUND SERIES TRUST | 2.08% |
| 5 | Fidelity | 1.98% |
| 6 | Dimensional | 1.05% |
| 7 | T. Rowe Price | 0.74% |
| 8 | FRANKLIN STRATEGIC SERIES | 0.59% |
| 9 | Charles Schwab | 0.54% |
| 10 | Victory Capital | 0.45% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | EcoR1 Capital, LLC | 27.53% |
| 2 | Boxer Capital, LLC | 4.70% |
| 3 | State Street | 4.13% |
| 4 | GREAT POINT PARTNERS LLC | 3.33% |
| 5 | First Light Asset Management, LLC | 3.24% |
| 6 | Palo Alto Investors LP | 2.94% |
| 7 | BlackRock | 2.52% |
| 8 | FRANKLIN ADVISERS INC | 1.70% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.55% |
| 10 | Woodline Partners LP | 1.46% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| EcoR1 Capital LLC | 27.53% | DEF14A |
| Oleg Nodelman | 27.53% | DEF14A |
| Deep Track Capital, LP | 7.46% | DEF14A |
| Tang Capital Partners, L.P. | 7.14% | DEF14A |
| BlackRock | 6.31% | 13F |
| Morgan Stanley | 5.70% | 13F |
| Vanguard Group | 5.41% | 13F |
| State Street | 4.42% | 13F |
| Point72 | 3.16% | 13F |
| Millennium Management | 2.37% | 13F |
Percentages above are of 27,316,644 shares outstanding, as reported by ANAPTYSBIO INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ANAPTYSBIO INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At ANAPTYSBIO INC.'s shareholder meeting held June 12, 2024, in the 2023-2024 proxy season, 168 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 1,120 separate fund positions. On the most widely held item on that ballot — TO CONDUCT A NON-BINDING ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS… — FOR was 87% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ANAPTYSBIO INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 12, 2024.
ANAPTYSBIO INC. proxy season coverage: 2023-2024 (this page) · 2024-2025.
Download data (CSV): ballot items · votes by manager · column guide.